Pediatric Vaccines Market Size, Share & Industry Analysis, By Type (Live Attenuated, Inactivated, Recombinant/Conjugate/Subunit, mRNA Vaccine, and Others), By Disease Indication (Viral Diseases {Hepatitis A, Hepatitis B, Polio, RSV, Influenza, HPV, Measles/Mumps/Rubella, Rotavirus, Shingles and Others} and Bacterial Diseases {Pneumococcal Diseases, Diphtheria/Tetanus/Pertussis, Meningococcal Diseases and Others}), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others), and Regional Forecasts, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113756

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Regulatory Scenarios, By Key Countries/Regions
2. Vaccination Coverage- By Key Countries/ Regions
3. Government Immunization Programs for Children- By Key Countries/ Regions
4. Technological Advancements in Pediatric Vaccines Market
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Bharat Biotech.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. GSK plc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. SINOVAC
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Serum Institute of India Pvt. Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Panacea Biotec
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Bio Farma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. AJ Vaccines A/S
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Beijing Institute of Biological Products Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Regulatory Scenarios, By Key Countries/Regions
2. Vaccination Coverage- By Key Countries/ Regions
3. Government Immunization Programs for Children- By Key Countries/ Regions
4. Technological Advancements in Pediatric Vaccines Market
5. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
Global Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. U.K.
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Pediatric Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Live Attenuated
  2. Inactivated
  3. Recombinant/Conjugate/Subunit
  4. mRNA Vaccine
  5. Viral Vectors Vaccines
  6. Toxoid
  7. Others
2. Market Analysis, Insights and Forecast – By Disease Indication
  1. Viral Diseases
    1. Hepatitis A
    2. Hepatitis B
    3. Polio
    4. RSV
    5. Influenza
    6. HPV
    7. MMR
    8. Rotavirus
    9. Shingles
    10. Others
  2. Bacterial Diseases
    1. Pneumococcal Diseases
    2. DTP
    3. Meningococcal Diseases
    4. Others
3. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles
  1. Merck & Co., Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Sanofi.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Bharat Biotech.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. GSK plc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. SINOVAC
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Serum Institute of India Pvt. Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Panacea Biotec
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Bio Farma
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. AJ Vaccines A/S
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  11. Beijing Institute of Biological Products Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Pediatric Vaccines Market Revenue Breakdown (USD billion, %), By Region, 2024 & 2032

Figure 2: Global Pediatric Vaccines Market Value Share (%), By Type, 2024 & 2032

Figure 3: Global Pediatric Vaccines Market Value Share (%), By Disease Indication, 2024 & 2032

Figure 4: Global Pediatric Vaccines Market Value Share (%), By Route of Administration, 2024 & 2032

Figure 5: Global Pediatric Vaccines Market Value Share (%), By Distribution Channel, 2024 & 2032

Figure 6: Global Pediatric Vaccines Market Value Share (%), By Region, 2024 & 2032

Figure 7: North America Pediatric Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 8: North America Pediatric Vaccines Market Value Share (%), By Type, 2024

Figure 9: North America Pediatric Vaccines Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 10: North America Pediatric Vaccines Market Value Share (%), By Disease Indication, 2024

Figure 11: North America Pediatric Vaccines Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 12: North America Pediatric Vaccines Market Value Share (%), By Route of Administration, 2024

Figure 13: North America Pediatric Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 14: North America Pediatric Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 15: North America Pediatric Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 16: North America Pediatric Vaccines Market Value Share (%), By Country, 2024

Figure 17: Europe Pediatric Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 18: Europe Pediatric Vaccines Market Value Share (%), By Type, 2024

Figure 19: Europe Pediatric Vaccines Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 20: Europe Pediatric Vaccines Market Value Share (%), By Disease Indication, 2024

Figure 21: Europe Pediatric Vaccines Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 22: Europe Pediatric Vaccines Market Value Share (%), By Route of Administration, 2024

Figure 23: Europe Pediatric Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 24: Europe Pediatric Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 25: Europe Pediatric Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe Pediatric Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific Pediatric Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 28: Asia Pacific Pediatric Vaccines Market Value Share (%), By Type, 2024

Figure 29: Asia Pacific Pediatric Vaccines Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 30: Asia Pacific Pediatric Vaccines Market Value Share (%), By Disease Indication, 2024

Figure 31: Asia Pacific Pediatric Vaccines Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 32: Asia Pacific Pediatric Vaccines Market Value Share (%), By Route of Administration, 2024

Figure 33: Asia Pacific Pediatric Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 34: Asia Pacific Pediatric Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 35: Asia Pacific Pediatric Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific Pediatric Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Latin America Pediatric Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 38: Latin America Pediatric Vaccines Market Value Share (%), By Type, 2024

Figure 39: Latin America Pediatric Vaccines Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 40: Latin America Pediatric Vaccines Market Value Share (%), By Disease Indication, 2024

Figure 41: Latin America Pediatric Vaccines Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 42: Latin America Pediatric Vaccines Market Value Share (%), By Route of Administration, 2024

Figure 43: Latin America Pediatric Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 44: Latin America Pediatric Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 45: Latin America Pediatric Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 46: Latin America Pediatric Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 47: Middle East & Africa Pediatric Vaccines Market Value (USD billion), By Type, 2024 & 2032

Figure 48: Middle East & Africa Pediatric Vaccines Market Value Share (%), By Type, 2024

Figure 49: Middle East & Africa Pediatric Vaccines Market Value (USD billion), By Disease Indication, 2024 & 2032

Figure 50: Middle East & Africa Pediatric Vaccines Market Value Share (%), By Disease Indication, 2024

Figure 51: Middle East & Africa Pediatric Vaccines Market Value (USD billion), By Route of Administration, 2024 & 2032

Figure 52: Middle East & Africa Pediatric Vaccines Market Value Share (%), By Route of Administration, 2024

Figure 53: Middle East & Africa Pediatric Vaccines Market Value (USD billion), By Distribution Channel, 2024 & 2032

Figure 54: Middle East & Africa Pediatric Vaccines Market Value Share (%), By Distribution Channel, 2024

Figure 55: Middle East & Africa Pediatric Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 56: Middle East & Africa Pediatric Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 57: Global Pediatric Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 2: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 3: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Viral Diseases, 2019–2032

Table 4: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Bacterial Diseases, 2019–2032

Table 5: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 6: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 7: Global Pediatric Vaccines Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 8: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 9: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 10: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Viral Diseases, 2019–2032

Table 11: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Bacterial Diseases, 2019–2032

Table 12: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 13: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 14: North America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 15: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 16: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 17: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Viral Diseases, 2019–2032

Table 18: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Bacterial Diseases, 2019–2032

Table 19: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 20: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 21: Europe Pediatric Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 22: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 23: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 24: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Viral Diseases, 2019–2032

Table 25: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Bacterial Diseases, 2019–2032

Table 26: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 27: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 28: Asia Pacific Pediatric Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 29: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 30: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 31: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Viral Diseases, 2019–2032

Table 32: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Bacterial Diseases, 2019–2032

Table 33: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 34: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 35: Latin America Pediatric Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 36: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 37: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Disease Indication, 2019–2032

Table 38: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Viral Diseases, 2019–2032

Table 39: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Bacterial Diseases, 2019–2032

Table 40: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2032

Table 41: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Route of Administration, 2019–2032

Table 42: Middle East & Africa Pediatric Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 159

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com